1. Home
  2. ATEC vs TLX Comparison

ATEC vs TLX Comparison

Compare ATEC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$19.80

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$8.63

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEC
TLX
Founded
1990
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ATEC
TLX
Price
$19.80
$8.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$22.00
$21.00
AVG Volume (30 Days)
2.1M
115.0K
Earning Date
10-30-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$728,020,000.00
$664,225,558.00
Revenue This Year
$26.83
N/A
Revenue Next Year
$16.61
N/A
P/E Ratio
N/A
$273.17
Revenue Growth
27.11
55.35
52 Week Low
$8.70
$8.76
52 Week High
$22.66
$30.36

Technical Indicators

Market Signals
Indicator
ATEC
TLX
Relative Strength Index (RSI) 46.75 34.46
Support Level $19.77 $9.37
Resistance Level $21.42 $10.03
Average True Range (ATR) 0.69 0.26
MACD -0.36 -0.05
Stochastic Oscillator 6.54 2.25

Price Performance

Historical Comparison
ATEC
TLX

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: